More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Spike (JN.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)
Fluorescence microscopy of ACE2-HEK293 cells transduced with Spike (JN.1, Omicron Variant) Pseudotyped Lentivirus (eGFP Reporter).
Fluorescence microscopy of ACE2-HEK293 cells transduced with Spike (JN.1, Omicron Variant) Pseudotyped Lentivirus (eGFP Reporter).
Fluorescence microscopy of ACE2-HEK293 cells transduced with Spike (JN.1, Omicron Variant) Pseudotyped Lentivirus (eGFP Reporter).

Spike (JN.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)

Research Use Only
78983
BPS Bioscience
Product group Expression
Price on request
Packing Size
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    BPS Bioscience
  • Product Name
    Spike (JN.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)
  • Delivery Days Customer
    7
  • Certification
    Research Use Only
  • Scientific Description
    The Spike (JN.1 Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter) are replication incompetent, HIV-based lentiviral particles. They were produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1 containing all the Omicron JN.1 mutations; see below for details) as the envelope glycoprotein, instead of the commonly used VSV-G. These pseudovirions also contain an eGFP reporter driven by a CMV promoter, allowing to measure the spike-mediated cell entry using the eGFP fluorescence signal. The pseudovirions have been validated in a cellular assay with ACE2-HEK293 Recombinant Cell Line (#79951), a cell line that overexpresses ACE2 at high levels, as target cell line.
  • Storage Instruction
    -80°C
  • UNSPSC
    41106621